Healthcare >> CEO Interviews >> May 11, 2000

John Baiyle – Dendrite International Inc (drte)

JOHN E. BAIYLE is the Chairman and CEO of Dendrite International, Inc. A graduate of the University of New South Wales, John Bailye joined and later purchased Foresearch, a small market research firm in his native Sydney, Australia. Mr. Bailye focused his new firm on the pharmaceutical industry and spearheaded its entry into the international marketplace. In 1986, he established Dendrite International, Inc. to pioneer the development of software applications for pharmaceutical sales force management. In 1987, he relocated Dendrite's headquarters and many key staff from Australia to New Jersey. Since his move to the United States, Mr. Bailye has expanded Dendrite International to over 1,200 employees with offices throughout North America, South America, Europe and Asia. He has taken the company from $250,000 in sales in 1986 to $112.5 million in 1998, establishing Dendrite as the worldwide leader in its market sector. Both Mr. Bailye and Dendrite have won wide industry recognition. In 1993, and again in 1998, Mr. Bailye was named New Jersey's Software and Technology Entrepreneur of the Year by Ernst & Young and was a National Finalist in 1998. Mr. Bailye has also received the Golden Door Award from the New Jersey International Institute in 1998, which recognizes those who have come to the United States and achieved commercial success. Mr. Bailye is a strong supporter of entrepreneurialism and technology growth in New Jersey and, through Dendrite, he is a Founding member of the New Jersey Technology Council. Profile
TWST: Give us an brief overview of Dendrite International.

Mr. Bailye: Dendrite supplies the software and supporting services and

tools that the world's biggest pharmaceutical companies use to